Novartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company leaders give an overview of its drug pipeline.
Ping An Technology has announced it has completed a clinical trial of the world’s first intelligent optical coherence tomography retinal disease screening system.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
